Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Department for Business, Energy and Industrial Strategy (BEIS)
1 Victoria Street
London
SW1H 0ET
UK
Telephone: +44 2072155000
E-mail: VTFContracts@beis.gov.uk
NUTS: UKI
Internet address(es)
Main address: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
General public services
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
SARS-COV-2 Vaccine Supply Agreement
Reference number: 4681/10/2020
II.1.2) Main CPV code
33651600
II.1.3) Type of contract
Supplies
II.1.4) Short description
Procurement of Novavax’s vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
UNITED KINGDOM.
II.2.4) Description of the procurement
Procurement of Novavax’s vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments; and
(ii) the contracting authority in negotiations with other vaccine vendors.
It may also impact fair competition between vaccine vendors.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights
Explanation
A direct contract with Novavax Inc. without competition is necessary for unforeseeable reasons of extreme urgency i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). In addition, competition was absent because Novavax has exclusive rights to this candidate vaccine (Reg 32(2)(b)(iii)).
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
Contract No: 4681/10/2020
Title: SARS-COV-2 Vaccine Supply Agreement
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
22/10/2020
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Novavax Inc.
222816046
21 Firstfield Road
Gaithersburg
20878
US
NUTS: 00
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Also, given significant competition to bring to the market a successful vaccine, provision of the contract term is valuable information to competitors that may impact negotiations/future competition.
To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=546544487
Go reference: GO-20201123-PRO-17405639
VI.4) Procedures for review
VI.4.1) Review body
Department of Business, Energy and Industrial Strategy
1 Victoria Street, Westminister
London
SW1H 0ET
UK
VI.5) Date of dispatch of this notice
23/11/2020